Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
504.00    -1.00 (-0.20%)
Bid:
503.00
Ask:
505.00
Spread: 2.00 (0.398%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Board Changes

30 Dec 2020 13:00

RNS Number : 1356K
Tate & Lyle PLC
30 December 2020
 

30 December 2020

 

Tate & Lyle PLC

 

 

BOARD CHANGES

 

Tate & Lyle PLC (the "Company") announces that John Cheung will join the Board as a non-executive director and a member of the Audit and Nominations Committees on 1 January 2021.

 

Currently an executive director of nutrition group China Feihe Limited, John brings a breadth of food and beverage experience with a deep understanding of markets in Asia, particularly in China. In a career spanning 30 years in the fields of nutrition, food and beverages, John has served as President for Wyeth Nutrition Global, having previously served as Nestlé Group's leader in China and earlier held senior roles with Coca-Cola and Procter & Gamble.

 

After nearly nine years on the Board, the Company also announces that non-executive director, Dr Ajai Puri, will retire on 31st March 2021.

 

Dr Gerry Murphy, Chairman of Tate & Lyle, said: "I am delighted that John has agreed to join the Board. His appointment recognises the importance of the Asia Pacific region to Tate & Lyle's growth and development. His substantial experience in the Chinese and broader Asian food and beverage industry will be of significant benefit to the Board.

 

I also thank Dr Puri for his nine years of dedicated service and significant contribution to the Board and, in particular, for his time as Chairman of our Research Advisory Group. Ajai's wisdom, technological insights and management experience have been exceptionally valuable as Tate & Lyle has evolved into a global, science-led food ingredient business."

 

There are no further disclosures to be made in connection with Mr Cheung's appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority's Listing Rules.

 

END

 

For more information contactNick Hasell, FTI Consulting (Media)Tel: Mobile: +44 (0) 7825 523 383

Christopher Marsh, VP, Investor Relationschris.marsh@tateandlyle.com / +44 (0) 7796 192 688

 

About Tate & Lyle: Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,200 employees working in more than 60 locations across 30 countries. Tate & Lyle's purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or Linkedin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPGQCPUPUUBU
Date   Source Headline
16th Jun 20164:40 pmBUSDirector/PDMR Shareholding
1st Jun 201610:17 amBUSTotal Voting Rights
26th May 20167:00 amBUSFinal Results
3rd May 20163:20 pmBUSHolding(s) in Company
5th Apr 20167:00 amBUSTrading Statement
1st Apr 20169:32 amBUSTotal Voting Rights
11th Mar 201610:00 amBUSDirectorate Change
2nd Mar 201611:37 amBUSDirector/PDMR Shareholding
12th Feb 20164:27 pmBUSDirector/PDMR Shareholding
11th Feb 20164:48 pmBUSDirector/PDMR Shareholding
11th Feb 20167:00 amBUSTrading Statement
14th Jan 20167:00 amBUSTate & Lyle Capital Markets Event
8th Jan 201611:51 amBUSDirector/PDMR Shareholding
5th Jan 20163:31 pmBUSDirector/PDMR Shareholding
4th Jan 20169:56 amBUSBlocklisting Interim Review
11th Dec 201511:49 amBUSDirector/PDMR Shareholding
4th Dec 201510:48 amBUSDirector/PDMR Shareholding
2nd Dec 201510:28 amBUSHolding(s) in Company
1st Dec 201510:17 amBUSTotal Voting Rights
9th Nov 20152:41 pmBUSDirector/PDMR Shareholding
5th Nov 20157:00 amBUSHalf-yearly Report
2nd Nov 20152:07 pmBUSTotal Voting Rights
2nd Nov 20151:22 pmBUSTate & Lyle Completes Re-Alignment of Eaststarch Joint Venture
8th Oct 20157:00 amBUSTrading Statement
29th Sep 20152:58 pmBUSJudgment re litigation
1st Sep 20159:59 amBUSTotal Voting Rights
25th Aug 20154:49 pmBUSDirector/PDMR Shareholding
4th Aug 20154:37 pmBUSDirector/PDMR Shareholding
30th Jul 20152:16 pmBUSDirector/PDMR Shareholding
29th Jul 20154:45 pmBUSResult of AGM
29th Jul 20157:00 amBUSTrading Statement
22nd Jul 201510:43 amBUSIssue of Debt
13th Jul 20154:52 pmBUSHolding(s) in Company
10th Jul 20154:34 pmBUSDirector/PDMR Shareholding
8th Jul 20152:52 pmBUSDirector/PDMR Shareholding
2nd Jul 201511:46 amBUSDirector/PDMR Shareholding
1st Jul 20152:42 pmBUSDirectorate Change
1st Jul 201510:09 amBUSBlocklisting Interim Review
1st Jul 20159:55 amBUSTotal Voting Rights
29th Jun 20154:51 pmBUSAnnual Financial Report
25th Jun 20151:57 pmBUSDirector/PDMR Shareholding
24th Jun 20156:16 pmBUSDirector/PDMR Shareholding
11th Jun 201510:33 amBUSDirector/PDMR Shareholding
10th Jun 201511:20 amBUSDirector/PDMR Shareholding
29th May 201510:03 amBUSDirector/PDMR Shareholding
28th May 20153:36 pmBUSDirector/PDMR Shareholding
28th May 20157:00 amBUSFinal Results
12th May 201510:30 amBUSHolding(s) in Company
1st May 201512:17 pmBUSTotal Voting Rights
21st Apr 201510:21 amBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.